Summary:
We are seeking participants for a new clinical research study to evaluate the effectiveness of a ONCE WEEKLY administration of basal (long-acting) insulin investigational medication compared to DAILY administration of insulin glargine (long-acting) in Type 2 Diabetics.
Criteria:- 18 years of age or older
- Diagnosis of type 2 diabetes
- Have an HbA1c value of 7.0% to 10.0%, inclusive
- Body Mass Index (BMI) less than or equal to 45kg/m²
- Additional qualification criteria exist
Qualified Participants May Receive:
- Reimbursement available for time and travel
- Study-related care, study medicine, insulin and study supplies will be provided at no cost (no health insurance required)